Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi to manufacture Moderna COVID-19 vaccine
The deal involves up to 200 million doses of Moderna's two-shot vaccine
Gilead Sciences to support expansion of local production capacity of Remdesivir in India
Gilead will donate a minimum of 450,000 vials of Veklury to the Government of India
MSD signs voluntary licensing agreements with five Indian pharma firms for Molnupiravir
The agreements have been signed with Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical…
Syngene extends research partnership with Bristol Myers Squibb until 2030
The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq. ft. dedicated…
Kemwell Biopharma increases capacity for manufacturing of biologics
The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical…
India should step up vaccination rate, enable oxygen supplies to control COVID-19 pandemic:…
The variant, B.1.617, alongwith several other aspects including the low percentage of vaccinated persons, large religious and…
Mankind Pharma to give Rs 100 cr to families of deceased frontline COVID warriors
The company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma…
Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis
It is a novel fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for the treatment of symptoms…
NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…
Future-ready supply chains
The COVID-19 pandemic has several lessons for India Pharma Inc as it embraces new strategies and technologies to rebuild and…